BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
BioGaia EPS Diluted (Quarterly): 0.1167 for March 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.1167 |
December 31, 2023 | 0.0631 |
September 30, 2023 | 0.0936 |
June 30, 2023 | 0.0761 |
March 31, 2023 | 0.1103 |
December 31, 2022 | 0.1292 |
September 30, 2022 | 0.0753 |
June 30, 2022 | 0.0797 |
March 31, 2022 | 0.0816 |
December 31, 2021 | 0.043 |
September 30, 2021 | 0.0602 |
June 30, 2021 | 0.0642 |
March 31, 2021 | 0.0597 |
December 31, 2020 | 0.047 |
September 30, 2020 | 0.0264 |
June 30, 2020 | 0.0935 |
March 31, 2020 | 0.0501 |
December 31, 2019 | 0.0612 |
September 30, 2019 | 0.0457 |
June 30, 2019 | 0.0745 |
March 31, 2019 | 0.045 |
December 31, 2018 | 0.0818 |
September 30, 2018 | 0.0664 |
June 30, 2018 | 0.0744 |
March 31, 2018 | 0.0615 |
Date | Value |
---|---|
December 31, 2017 | 0.067 |
September 30, 2017 | 0.0598 |
June 30, 2017 | 0.0618 |
March 31, 2017 | 0.0554 |
December 31, 2016 | 0.06 |
September 30, 2016 | 0.0474 |
June 30, 2016 | 0.0541 |
March 31, 2016 | 0.1461 |
December 31, 2015 | 0.0294 |
September 30, 2015 | 0.028 |
June 30, 2015 | 0.0489 |
March 31, 2015 | 0.0601 |
December 31, 2014 | 0.0277 |
September 30, 2014 | 0.0242 |
June 30, 2014 | 0.0312 |
March 31, 2014 | 0.1743 |
December 31, 2013 | 0.0286 |
September 30, 2013 | 0.0238 |
June 30, 2013 | 0.0272 |
March 31, 2013 | 0.0302 |
December 31, 2012 | 0.0259 |
September 30, 2012 | 0.0237 |
June 30, 2012 | 0.0259 |
March 31, 2012 | 0.4852 |
December 31, 2011 | 0.035 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
0.0264
Minimum
Sep 2020
0.1292
Maximum
Dec 2022
0.0725
Average
0.0642
Median
Jun 2021
EPS Diluted (Quarterly) Benchmarks
Abliva AB | -0.0019 |
Karolinska Development AB | 0.0001 |
Calliditas Therapeutics AB | -0.8851 |
Oncopeptides AB | -0.0417 |
Olink Holding AB | -0.13 |
EPS Diluted (Quarterly) Related Metrics
Net Income (Quarterly) | 11.75M |
Revenue (Quarterly) | 35.65M |
Total Expenses (Quarterly) | 21.85M |
Enterprise Value | 1.012B |
Gross Profit Margin (Quarterly) | 71.89% |
Profit Margin (Quarterly) | 32.95% |
Earnings Yield | 3.04% |
Operating Earnings Yield | 3.56% |
Normalized Earnings Yield | 3.040 |